Literature DB >> 25141254

Management of diabetic nephropathy in older patients: a need for flexible guidelines.

Ahmed H Abdelhafiz1, Meguid El Nahas, Jose M F de Oliveira.   

Abstract

As the population ages and diabetes mellitus increases in prevalence, the incidence of diabetic nephropathy (DN) is becoming a disease of older people (aged ≥ 75 years). As the epidemiology of diabetes mellitus and DN shifts toward this patient population, the pathogenesis of DN in old age is changing: the pathologic findings suggest ischemia and hypertension, and the classic Kimmelstiel-Wilson lesions may be absent. The demographic shift in the epidemiology and the associated changes in pathology because of aging and atherosclerosis will have a significant impact on various aspects related to the disease in old age. This article reviews the authors' current understanding of DN and its implications on clinical management relevant to current guidelines.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25141254     DOI: 10.3810/pgm.2014.07.2794

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  2 in total

1.  Clinical efficacy and safety of tripterygium glycosides in treatment of stage IV diabetic nephropathy: A meta-analysis.

Authors:  Yan Hong; Zhihong Gui; Xiaoping Cai; Lejian Lan
Journal:  Open Med (Wars)       Date:  2016-12-30

2.  Efficacy of tripterygium glycosides for diabetic nephropathy: a meta-analysis of randomized controlled trials.

Authors:  Hua-Bin Guo; Jia-Qing Peng; Ke-Kai Zhang; Guang-Zhi Zhong; Wei-Hong Chen; Gui-Xin Shi
Journal:  BMC Nephrol       Date:  2021-09-07       Impact factor: 2.388

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.